Sun Pharmaceutical Industries Limited vs Suven Life Sciences Limited
A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Suven Life Sciences Limited (SUVEN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, Sun Pharmaceutical Industries Limited leads SUNPHARMA vs SUVEN on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation31
- Profitability40
- Growth10
- Size & financial health31
Valuation
SUNPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
- − ["Stock is trading at 5.05 times its book value"]
- + ["Company is almost debt free."]
- − ["Stock is trading at 14.50 times its book value", "The company has delivered a poor sales growth of -11.4% over past five years.", "Company has a low return on equity of -65.4% over last 3 years.", "Company reported a net loss of ₹276 Cr in its latest financial year."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.